Acetato de Medroxiprogesterona de Depósito como Anticoncepcional Injetável em Adolescentes: Influence Statistics

Expert Impact

Concepts for which they have has direct influence: Weight gain , Medroxyprogesterone acetate , Acetate dmpa , Depot medroxyprogesterone , Acetato medroxiprogesterona , Medroxiprogesterona depósito .

Key People For Weight Gain

Top KOLs in the world
#1
Walter Churchill Willett
breast cancer type 2 diabetes coronary heart disease
#2
Katherine M Flegal
united states prevalence obesity blood lead levels
#3
Graham A Colditz
breast cancer physical activity united states
#4
Jo Ann E Manson
breast cancer postmenopausal women type 2 diabetes
#5
David B Allison
weight loss body composition united states
#6
Frank B Hu
type 2 diabetes cardiovascular disease physical activity

Acetato de Medroxiprogesterona de Depósito como Anticoncepcional Injetável em Adolescentes

Abstract

. Purpose: to evaluate the incidence of side effects and acceptance (continuity rate) of depot medroxyprogesterone acetate (DMPA) as an injectable three-monthly contraceptive given to adolescents in our milien. Method: forty adolescents (70% lactating) started to use DMPA and were followed-up for a mean of 14.2 months. Spontaneous complaints, menstrual changes, physical examination and laboratory data were collected and studied using Wilcoxon or McNemar tests. Results: the most frequent complaints were abdominal pain (16.6%) and headache (15.2%). Predominant menstrual patterns were spotting and oligomenorrhea. Significant variation of the systolic blood pressure was not observed during the follow-up. There was a slight fall in the levels of diastolic blood pressure, at the limit of significance. Significant deviations from baseline regarding fasting glucose were not noted, but the mean hemoglobin concentration tended to increase. Weight gain (mean 3.9 kg at 12 months) and menstrual irregularity (occurred in more than 70% of all visits) were the main reasons for discontinuation of the method. Twenty-seven patients were accompanied during 12 months and the continuity rate at that time was 81.5%. Conclusion: depot medroxyprogesterone acetate is a satisfactory contraceptive method for adolescents.